Medical Care

Multifocal motor neuropathy (MMN) is associated with slowly progressive weakness, but most patients are able to remain productive and employed. However, gradual progression may lead to significant disability. Physical and occupational therapy may be helpful in individual cases.

Diet

No specific diet is indicated for patients with MMN.

Activity

The level of activity depends on the extent of patient symptoms and disability.

Medication

Taylor BV, Wright RA, Harper CM, Dyck PJ. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve. 2000 Jun. 23(6):900-8. [QxMD MEDLINE Link].
Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology. 2007 Oct 23. 69(17):1680-7. [QxMD MEDLINE Link].
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision. J Peripher Nerv Syst. 2010 Dec. 15(4):295-301. [QxMD MEDLINE Link].
Cocito D, Bergamasco B, Tavella A, Poglio F, Paolasso I, Costa P, et al. Multifocal motor neuropathy during treatment with infliximab. J Peripher Nerv Syst. 2005 Dec. 10(4):386-7. [QxMD MEDLINE Link].
Harschnitz O, van den Berg LH, Johansen LE, Jansen MD, Kling S, Vieira de Sá R, et al. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model. Ann Neurol. 2016 Jul. 80 (1):71-88. [QxMD MEDLINE Link].
Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci. 2007 Apr 11. 27(15):3956-67. [QxMD MEDLINE Link].
Yuki N, Watanabe H, Nakajima T, Späth PJ. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry. 2010 Jul 28. [QxMD MEDLINE Link].
Taylor BV, Dyck PJ, Engelstad J, Gruener G, Grant I, Dyck PJ. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol. 2004 Feb. 63(2):129-37. [QxMD MEDLINE Link].
Löscher WN, Oberreiter EM, Erdler M, Quasthoff S, Culea V, Berek K, et al. Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment. J Neurol. 2018 Sep 26. [QxMD MEDLINE Link].
Miyashiro A, Matsui N, Shimatani Y, Nodera H, Japanese Multifocal Motor Neuropathy Study Group. Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan. Muscle Nerve. 2014 Mar. 49 (3):357-61. [QxMD MEDLINE Link].
Erdmann PG, Lindeman E, Cats EA, van den Berg LH. Functioning of patients with multifocal motor neuropathy. J Peripher Nerv Syst. 2010 Jun. 15(2):113-9. [QxMD MEDLINE Link].
Lange DJ, Weimer LH, Trojaborg W, et al. Multifocal motor neuropathy with conduction block: slow but not benign. Arch Neurol. 2006 Dec. 63(12):1778-81. [QxMD MEDLINE Link].
Ishigaki H, Hiraide T, Miyagi Y, Hayashi T, Matsubayashi T, Shimoda A, et al. Childhood-Onset Multifocal Motor Neuropathy With Immunoglobulin M Antibodies to Gangliosides GM1 and GM2: A Case Report and Review of the Literature. Pediatr Neurol. 2016 Sep. 62:51-7. [QxMD MEDLINE Link].
Bromberg MB, Franssen H. Practical rules for electrodiagnosis in suspected multifocal motor neuropathy. J Clin Neuromuscul Dis. 2015 Mar. 16 (3):141-52. [QxMD MEDLINE Link].
Boonyapisit K, Katirji B. Multifocal motor neuropathy presenting with respiratory failure. Muscle Nerve. 2000 Dec. 23(12):1887-90. [QxMD MEDLINE Link].
Straver DC, van Asseldonk JT, Notermans NC, Wokke JH, van den Berg LH, Franssen H. Cold paresis in multifocal motor neuropathy. J Neurol. 2011 Feb. 258(2):212-7. [QxMD MEDLINE Link]. [Full Text].
Nobile-Orazio E, Giannotta C, Musset L, Messina P, Léger JM. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry. 2013 Aug 1. [QxMD MEDLINE Link].
Notturno F, Di Febo T, Yuki N, Fernandez Rodriguez BM, Corti D, Nobile-Orazio E, et al. Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy. J Neuroimmunol. 2014 Nov 15. 276 (1-2):207-12. [QxMD MEDLINE Link].
Pestronk A, Chuquilin M, Choksi R. Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside. J Neurol Neurosurg Psychiatry. 2010 Jul. 81 (7):726-30. [QxMD MEDLINE Link].
Beekman R, van den Berg LH, Franssen H, Visser LH, van Asseldonk JT, Wokke JH. Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy. Neurology. 2005. 65:305-7. [QxMD MEDLINE Link].
Vucic S, Black KR, Chong PS, Cros D. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology. 2004 Oct 12. 63(7):1264-9. [QxMD MEDLINE Link].
Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain. 2002 Aug. 125(Pt 8):1875-86. [QxMD MEDLINE Link].
Cats EA, van der Pol WL, Piepers S, Franssen H, Jacobs BC, van den Berg-Vos RM, et al. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology. 2010 Aug 31. 75(9):818-25. [QxMD MEDLINE Link].
Markvardsen LH, Harbo T. Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs. J Neurol Sci. 2017 Jul 15. 378:19-25. [QxMD MEDLINE Link].
Katzberg HD, Rasutis V, Bril V. Subcutaneous immunoglobulin for treatment of multifocal motor neuropathy. Muscle Nerve. 2016 Nov. 54 (5):856-863. [QxMD MEDLINE Link].
Ruegg SJ, Fuhr P, Steck AJ. Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg. Neurology. 2004 Dec 14. 63(11):2178-9. [QxMD MEDLINE Link].
Pestronk A, Florence J, Miller T, et al. Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatry. 2003 Apr. 74(4):485-9. [QxMD MEDLINE Link].
Stieglbauer K, Topakian R, Hinterberger G, Aichner FT. Beneficial effect of rituximab monotherapy in multifocal motor neuropathy. Neuromuscul Disord. 2009 Jul. 19(7):473-5. [QxMD MEDLINE Link].
[Guideline] Hughes RA. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst. 2006 Mar. 11(1):1-8. [QxMD MEDLINE Link].
Nemni R, Santuccio G, Calabrese E, Galardi G, Canal N. Efficacy of cyclosporine treatment in multifocal motor neuropathy. J Neurol. 2003 Sep. 250(9):1118-20. [QxMD MEDLINE Link].
{Best Evidence} Umapathi T, Hughes RA, Nobile-Orazio E, Léger JM. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev. 2012 Apr 18. 4:CD003217. [QxMD MEDLINE Link].
Vlam L, Cats EA, Willemse E, Franssen H, Medic J, Piepers S, et al. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry. 2013 Dec 11. [QxMD MEDLINE Link].
Harbo T, Andersen H, Jakobsen J. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy. Neurology. 2010 Oct 12. 75(15):1377-80. [QxMD MEDLINE Link].
Axelson HW, Oberg G, Askmark H. No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy. Acta Neurol Scand. 2008 Jun. 117(6):432-4. [QxMD MEDLINE Link].
Harbo T, Andersen H, Jakobsen J. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy. Neurology. 2010 Oct 12. 75(15):1377-80. [QxMD MEDLINE Link].
Lambrecq V, Krim E, Rouanet-Larrivière M, Lagueny A. Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological study. Muscle Nerve. 2009 Feb. 39(2):131-6. [QxMD MEDLINE Link].
Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve. 2005 Jun. 31(6):663-80. [QxMD MEDLINE Link].
Vlam L, van der Pol WL, Cats EA, Straver DC, Piepers S, Franssen H, et al. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol. 2011 Nov 22. 8(1):48-58. [QxMD MEDLINE Link].
Jongbloed BA, Haakma W, Goedee HS, Bos JW, Bos C, Hendrikse J, et al. Comparative study of peripheral nerve Mri and ultrasound in multifocal motor neuropathy and amyotrophic lateral sclerosis. Muscle Nerve. 2016 Dec. 54 (6):1133-1135. [QxMD MEDLINE Link].

Media Gallery

Nerve conduction studies demonstrating conduction block with temporal dispersion after proximal stimulation.

of 1

Author

Sasa Zivkovic, MD, PhD Professor, Department of Neurology, Division of Neuromuscular Diseases, University of Pittsburgh School of Medicine

Sasa Zivkovic, MD, PhD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Peripheral Nerve Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Alnylam Pharmaceuticals; Akcea Therapeutics.

Coauthor(s)

Michael C Isfort, MD Resident Physician, Department of Neurology, University of Pittsburgh Medical Center

Michael C Isfort, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, American Neurological Association, Gold Humanism Honor Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Glenn Lopate, MD Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University in St Louis School of Medicine; Consulting Staff, Department of Neurology, Barnes-Jewish Hospital

Glenn Lopate, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Nicholas Lorenzo, MD, CPE, MHCM, FAAPL Co-Founder and Former Chief Publishing Officer, eMedicine and eMedicine Health, Founding Editor-in-Chief, eMedicine Neurology; Founder and Former Chairman and CEO, Pearlsreview; Founder and CEO/CMO, PHLT Consultants; Former Chief Medical Officer, MeMD Inc

Nicholas Lorenzo, MD, CPE, MHCM, FAAPL is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Association for Physician Leadership

Disclosure: Nothing to disclose.

Additional Contributors

Paul E Barkhaus, MD, FAAN, FAANEM Professor of Neurology and Physical Medicine and Rehabilitation, Chief, Neuromuscular and Autonomic Disorders Program, Director, ALS Program, Department of Neurology, Medical College of Wisconsin

Paul E Barkhaus, MD, FAAN, FAANEM is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Clinical Neurophysiology Society, American Neurological Association

Disclosure: Nothing to disclose.